AMOD vs CDLX

Alpha Modus Holdings, Inc.

(AMOD) offers the better valuation at 0. 3x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Alpha Modus Holdings, Inc.

(AMOD) delivered a total return of -97. 8%, compared to -99. 2% for Cardlytics, Inc. (CDLX). Over 10 years, the gap is even starker: CDLX returned -94. 2% versus AMOD's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Alpha Modus Holdings, Inc.

(AMOD) is the lower-risk stock at 1. 51β versus Cardlytics, Inc. 's 3. 18β — meaning CDLX is approximately 111% more volatile than AMOD relative to the S&P 500.

On earnings-per-share growth, the picture is similar: Alpha Modus Holdings, Inc.

grew EPS 20. 3% year-over-year, compared to 50. 1% for Cardlytics, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alpha Modus Holdings, Inc.

(AMOD) is the more profitable company, earning 0. 0% net margin versus -44. 4% for Cardlytics, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMOD leads at 0. 0% versus -20. 2% for CDLX. At the gross margin level — before operating expenses — CDLX leads at 45. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Alpha Modus Holdings, Inc.

(AMOD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Cardlytics, Inc. (CDLX) carries a higher beta of 3. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMOD: -97. 8%, CDLX: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AMOD (Technology) and CDLX (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AMOD is a small-cap deep-value stock; CDLX is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.